Skip to Main Content

Paper Details

Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents.
Eur Urol
127
2014
Author NameAffiliation
Roberta FerraldeschiRoyal Marsden NHS Foundation Trust and Institute of Cancer Research
Johann S de BonoRoyal Marsden NHS Foundation Trust and Institute of Cancer Research
Gerhardt AttardRoyal Marsden NHS Foundation Trust and Institute of Cancer Research
  • 1 - 3

Datasets

Release 1.2